Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases

被引:85
作者
Torres-Sangiao, Eva [1 ]
Holban, Alina Maria [2 ,3 ]
Gestal, Monica Cartelle [4 ]
机构
[1] Univ Santiago de Compostela, Dept Microbiol & Parasitol, Galicia 15782, Spain
[2] Univ Bucharest, Dept Microbiol & Immunol, Fac Biol, Bucharest 060101, Romania
[3] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Sci & Engn Oxide Mat & Nanomat, Bucharest 060042, Romania
[4] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA
来源
MOLECULES | 2016年 / 21卷 / 07期
关键词
nanoparticles; vaccines; microbiology diagnosis; biofilm; antibiotic resistance; GANGLIOSIDE-LIPOSOME IMMUNOASSAY; ASSEMBLING PROTEIN NANOPARTICLES; ANTIGEN-DELIVERY-SYSTEM; DELTA INULIN; STAPHYLOCOCCUS-AUREUS; GOLD NANOPARTICLES; MAGNETIC NANOPARTICLES; SENSITIVE DETECTION; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE;
D O I
10.3390/molecules21070867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of nanoparticles has contributed to many advances due to their important properties such as, size, shape or biocompatibility. The use of nanotechnology in medicine has great potential, especially in medical microbiology. Promising data show the possibility of shaping immune responses and fighting severe infections using synthetic materials. Different studies have suggested that the addition of synthetic nanoparticles in vaccines and immunotherapy will have a great impact on public health. On the other hand, antibiotic resistance is one of the major concerns worldwide; a recent report of the World Health Organization (WHO) states that antibiotic resistance could cause 300 million deaths by 2050. Nanomedicine offers an innovative tool for combating the high rates of resistance that we are fighting nowadays, by the development of both alternative therapeutic and prophylaxis approaches and also novel diagnosis methods. Early detection of infectious diseases is the key to a successful treatment and the new developed applications based on nanotechnology offer an increased sensibility and efficiency of the diagnosis. The aim of this review is to reveal and discuss the main advances made on the science of nanomaterials for the prevention, diagnosis and treatment of infectious diseases. Highlighting innovative approaches utilized to: (i) increasing the efficiency of vaccines; (ii) obtaining shuttle systems that require lower antibiotic concentrations; (iii) developing coating devices that inhibit microbial colonization and biofilm formation.
引用
收藏
页数:22
相关论文
共 166 条
  • [1] Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes
    Agrawal, A
    Tripp, RA
    Anderson, LJ
    Nie, SM
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (13) : 8625 - 8628
  • [2] Detection of Influenza Virus Using Peroxidase-Mimic of Gold Nanoparticles
    Ahmed, Syed Rahin
    Kim, Jeonghyo
    Suzuki, Tetsuro
    Lee, Jaebeom
    Park, Enoch Y.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (10) : 2298 - 2303
  • [3] Ganglioside-liposome immunoassay for the ultrasensitive detection of cholera toxin
    Ahn-Yoon, S
    DeCory, TR
    Baeumner, AJ
    Durst, RA
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (10) : 2256 - 2261
  • [4] Ganglioside-liposome immunoassay for the detection of botulinum toxin
    Ahn-Yoon, S
    DeCory, TR
    Durst, RA
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2004, 378 (01) : 68 - 75
  • [5] Role and implications of nanodiagnostics in the changing trends of clinical diagnosis
    Alharbi, Khalid Khalaf
    Al-sheikh, Yazeed A.
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2014, 21 (02) : 109 - 117
  • [6] A universal polysaccharide conjugated vaccine against O111 E. coli
    Andrade, Gabrielle R.
    New, Roger R. C.
    Sant'Anna, Osvaldo A.
    Williams, Neil A.
    Alves, Rosely C. B.
    Pimenta, Daniel C.
    Vigerelli, Hugo
    Melo, Bruna S.
    Rocha, Leticia B.
    Piazza, Roxane M. F.
    Mendonca-Previato, Lucia
    Domingos, Marta O.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2864 - 2874
  • [7] OVERVIEW OF A 5-YEAR CLINICAL-EXPERIENCE WITH A YEAST-DERIVED HEPATITIS-B VACCINE
    ANDRE, FE
    [J]. VACCINE, 1990, 8 : S74 - S78
  • [8] Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
    Angsantikul, Pavimol
    Thamphiwatana, Soracha
    Gao, Weiwei
    Zhang, Liangfang
    [J]. VACCINES, 2015, 3 (04): : 814 - 828
  • [9] 'Plenty of room' revisited
    不详
    [J]. NATURE NANOTECHNOLOGY, 2009, 4 (12) : 781 - 781
  • [10] [Anonymous], F1000RESEARCH